Secant Medical, the sole Pennsylvania-based defendant in Philadelphia’s pelvic-mesh mass tort, has been dismissed from the litigation.

In an order Monday, Philadelphia Court of Common Pleas Judge Arnold L. New, coordinating judge of the Complex Litigation Center, dismissed Secant, finding the company was immune from liability as a biomaterials supplier under the Biomaterials Access Assurance Act of 1998.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]